Many brands have flirted with the headless concept, but not for long. One of the more notable marques to lose its head back in the decade of excess was Cort, who released, not one, not two, but a ...

Corcept Therapeutics (NasdaqCM:CORT) saw a remarkable 36% increase in its share price in the last quarter, driven by several key developments. The company's significant announcement on March 31 ...

$CORT insiders have traded $CORT stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales.